Citation

Csete J. Forensic Sci. Int. Mind Law 2020; 1: e100024.

Copyright

(Copyright © 2020, Elsevier Publishing)

DOI

10.1016/j.fsiml.2020.100024

PMID

unavailable

Abstract

Highlights

• Agonist therapy for opioid use disorder (OUD) is often inaccessible in the US at a time of high overdose mortality.
• OUD therapy could be offered by drug treatment courts as an alternative to criminal prosecution for some drug offenses.
• Many drug courts, however, reject gold-standard agonist therapies, seeing them as "another form of addiction".
• Drug courts often prefer to offer extended-release naltrexone, but it is costly and requires pre-treatment abstinence.
• Drug courts have had limited success in improving access to OUD treatment at a time of high overdose mortality.

Language: en

Keywords

Drug courts; Drug overdose; Drug treatment; Drug use disorders; Opioid use disorder